Evaluation of Parkinson Disease and Alzheimer Disease with the Use of Neuromelanin MR Imaging and¹²³I-Metaiodobenzylguanidine Scintigraphy

Abstract

Both neuromelanin MRI and (123)I-metaiodobenzylguanidine scintigraphy can help to evaluate disease progression in Parkinson disease and are useful for differentiating Parkinson disease from Alzheimer disease.